These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 723437)

  • 1. Decreased brain weights in rats after long-term barbital treatments.
    Wahlström G; Nordberg A
    Life Sci; 1978 Oct; 23(15):1583-90. PubMed ID: 723437
    [No Abstract]   [Full Text] [Related]  

  • 2. Some aspects of the changes induced by chronic barbital treatments in the male rat.
    Wahlström G
    Drug Alcohol Depend; 1979; 4(3-4):221-33. PubMed ID: 575087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of brain sensitivity to the convulsive effects of choline and changes induced by chronic barbital treatments in the rat.
    Wahlström G
    Eur J Pharmacol; 1978 Oct; 51(3):219-27. PubMed ID: 710501
    [No Abstract]   [Full Text] [Related]  

  • 4. Retardation of ovarian compensatory hypertrophy by barbiturates in albino rats.
    Sindgi SB; Rao MA
    Indian J Exp Biol; 1975 Sep; 13(5):419-21. PubMed ID: 1218894
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in cholinergic function in rat brain late in abstinence after chronic barbital treatment.
    Nordberg A; Wahlström G
    Drug Alcohol Depend; 1981 Feb; 7(1):51-61. PubMed ID: 7215155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ethanol, barbital, and lorazepam on brain monoamines in rat lines selectively outbred for differential sensitivity to ethanol.
    Hellevuo K; Kiianmaa K
    Pharmacol Biochem Behav; 1988 Jan; 29(1):183-8. PubMed ID: 3353424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of rat brain protein synthesis to ethanol and sodium barbital.
    Tewari S; Greenberg SA; Do K; Grey PA
    Alcohol Drug Res; 1987; 7(4):243-58. PubMed ID: 3828001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory increase in synaptosomal aldehyde reductase activity in rat brain after chronic barbital treatment.
    Minegishi A; Fukumori R; Satoh T; Kitagawa H
    Biochem Pharmacol; 1981 Oct; 30(19):2657-62. PubMed ID: 7028043
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions.
    Mori H; Tanaka T; Nishikawa A; Takahashi M; Williams GM
    Gan; 1981 Oct; 72(5):798-801. PubMed ID: 7327380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term forced oral barbital administration on endogenous acetylcholine in different regions of rat brain.
    Nordberg A; Wahlström G
    Eur J Pharmacol; 1977 Jun; 43(3):237-42. PubMed ID: 559577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of low-Km NADPH-dependent aldehyde reductase activity in the brain by chronic treatment of rats with barbital.
    Fukumori R; Minegishi A; Satoh T; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):553-6. PubMed ID: 7022596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on acute tolerance to ethanol in the abstinence period after long-term barbital treatment in the rat.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):152-60. PubMed ID: 573957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar development of tolerance to barbital-induced inhibition of avoidance behavior and loss of righting reflex in rats.
    Richter JA; Harris PS; Hanford PV
    Pharmacol Biochem Behav; 1982 Mar; 16(3):467-71. PubMed ID: 7079283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of using a new binding substance in barbital and sodium barbital tablets].
    Zakrzhevskaia TN; Kuiantseva AM; Shatalova NV
    Farmatsiia; 1978; 27(2):19-23. PubMed ID: 640028
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional biosynthesis of acetylcholine in brain following forced oral chronic barbitone treatment to rat.
    Nordberg A; Wahlström G
    J Neurochem; 1979 Feb; 32(2):371-8. PubMed ID: 762554
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristic biotransformation of aminopyrine in rat when administered with barbital.
    Matsuyama K; Kado K; Nishiuchi M; Goromaru T; Tsuzuki O; Noda A; Iguchi S
    J Pharmacobiodyn; 1981 Jan; 4(1):28-34. PubMed ID: 7277190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]muscimol and [3H]quinuclidinyl benzilate binding in rat cortex in the abstinence after long-term barbital treatment.
    Nordberg A; Wahlström G; Eriksson B
    Acta Physiol Scand; 1986 Jan; 126(1):153-6. PubMed ID: 3006433
    [No Abstract]   [Full Text] [Related]  

  • 18. Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine.
    Hiasa Y; Kitahori Y; Ohshima M; Fujita T; Yuasa T; Konishi N; Miyashiro A
    Carcinogenesis; 1982; 3(10):1187-90. PubMed ID: 7172417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of barbital and lorazepam in the AT and ANT rats: motor performance and brain monoamine functions.
    Hellevuo K; Kiianmaa K; Juhakoski A
    Alcohol Alcohol Suppl; 1987; 1():647-51. PubMed ID: 2447906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to hexobarbital and supersensitivity to pilocarpine after chronic barbital treatments in the rat.
    Wahlstrŏm G; Ekwall T
    Eur J Pharmacol; 1976 Jul; 38(1):123-9. PubMed ID: 954821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.